Researchers are developing a dental implant that administers prescription drugs in small doses over continuous periods. Dubbed "Intellidrug," the implant would be placed inside a pair of prosthetic molars and would release dosages to be absorbed into the mouth's mucous membranes. Ideal for chronically ill patients with large prescription regimens as well as those with mental impairment, the Intellidrug would allow the patient to maintain consistent levels of the drug in the bloodstream. The prototype will be displayed on Feb. 27 at the MedTec trade fair in Stuttgart and will undergo clinical testing later this year.
The Intellidrug tooth implant [Gizmag]
a
